tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BFRI Stock Latest News

Biofrontera, Inc. Navigates Mixed Earnings Call
Company AnnouncementsBiofrontera, Inc. Navigates Mixed Earnings Call
4h ago
BFRI
Biofrontera reports Q3 EPS (62c) vs (98c) last year
PremiumThe Fly
Biofrontera reports Q3 EPS (62c) vs (98c) last year
15h ago
BFRI
Biofrontera Regains Nasdaq Compliance in November 2025
PremiumCompany Announcements
Biofrontera Regains Nasdaq Compliance in November 2025
3d ago
8K
BFRI
Roth views divestiture as ‘essentially found money’ for Biofrontera
PremiumThe Fly
Roth views divestiture as ‘essentially found money’ for Biofrontera
7d ago
BFRI
Biofrontera Completes Sale of Xepi US License
PremiumCompany Announcements
Biofrontera Completes Sale of Xepi US License
7d ago
8K
BFRI
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
PremiumThe FlyPelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
7d ago
BFRI
LGND
Biofrontera announces sale of license for Xepi Cream to Pelthos
Premium
The Fly
Biofrontera announces sale of license for Xepi Cream to Pelthos
7d ago
BFRI
PTHS
Biofrontera Finalizes U.S. Rights Acquisition Deal
Premium
Company Announcements
Biofrontera Finalizes U.S. Rights Acquisition Deal
20d ago
8K
BFRI
Biofrontera Completes Restructuring and Asset Purchase
PremiumCompany Announcements
Biofrontera Completes Restructuring and Asset Purchase
22d ago
8K
BFRI
Biofrontera Inc. close purchase of all Ameluz, RhodoLED U.S. assets
PremiumThe Fly
Biofrontera Inc. close purchase of all Ameluz, RhodoLED U.S. assets
22d ago
BFRI
Biofrontera Inc. price target lowered to $9 from $10 at Roth Capital
PremiumThe Fly
Biofrontera Inc. price target lowered to $9 from $10 at Roth Capital
1M ago
BFRI
Biofrontera Approves Key Proposals at Special Meeting
PremiumCompany Announcements
Biofrontera Approves Key Proposals at Special Meeting
2M ago
8K
BFRI
Biofrontera says last patient completes treatment in Phase 3 study of Ameluz
PremiumThe FlyBiofrontera says last patient completes treatment in Phase 3 study of Ameluz
2M ago
BFRI
Biofrontera, Inc. Reports Record Sales Amid Strategic Growth
Premium
Company Announcements
Biofrontera, Inc. Reports Record Sales Amid Strategic Growth
2M ago
BFRI
Biofrontera announces last-patient-out in Phase 2b study of Ameluz topical gel
Premium
The Fly
Biofrontera announces last-patient-out in Phase 2b study of Ameluz topical gel
3M ago
BFRI
Biofrontera Inc. Reports Revenue Growth Amid Strategic Restructuring
PremiumCompany Announcements
Biofrontera Inc. Reports Revenue Growth Amid Strategic Restructuring
3M ago
BFRI
Biofrontera Appoints New Chief Commercial Officer
PremiumCompany Announcements
Biofrontera Appoints New Chief Commercial Officer
3M ago
8K
BFRI
Biofrontera Inc. appoints George Jones as chief commercial officer
PremiumThe Fly
Biofrontera Inc. appoints George Jones as chief commercial officer
3M ago
BFRI
Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
3M ago
BFRI
Biofrontera Inc. files to sell 13.6M shares of common stock for holders
PremiumThe FlyBiofrontera Inc. files to sell 13.6M shares of common stock for holders
4M ago
BFRI
Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
Premium
Company Announcements
Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
5M ago
8K
BFRI
Biofrontera Restructures U.S. Rights with $11M Investment
Premium
Company Announcements
Biofrontera Restructures U.S. Rights with $11M Investment
5M ago
8K
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >